Skip to main content

Table 3 Association of corticosteroid use and lymphocytopenia with herpesvirus reactivation

From: Herpesvirus and neurological manifestations in patients with severe coronavirus disease

Viral type

Corticosteroid use

p

Lymphocytopenia

 

p

Total

Yes

N (%)

No

N (%)

Yes

N (%)

No

N (%)

HSV-1

Yes

8 (88.9)

1 (11.1)

0.129a

6 (66.7)

3 (33.3)

0.474a

9 (100)

No

25 (56.8)

19 (43.2)

 

22 (50)

22 (50)

 

44 (100)

HSV-2

Yes

1 (100)

0 (0)

1.000a

1 (100)

0 (0)

1.000a

1 (100)

No

32 (61.5)

20 (38.5)

 

27 (51.9)

25 (48.1)

 

52 (100)

EBV

Yes

11 (73.3)

4 (26.7)

0.296b

10 (66.7)

5 (33.3)

0.205b

15 (100)

No

22 (57.9)

16 (42.1)

 

18 (47.4)

20 (52.6)

 

38 (100)

CMV

Yes

12 (52.2)

11 (47.8)

0.185b

11 (47.8)

12 (52.2)

0.523b

23 (100)

No

21 (70)

9 (30)

 

17 (56.7)

13 (43.3)

 

30 (100)

VZV

Yes

2 (50)

2 (50)

0.627a

3 (75)

1 (25)

0.613a

4 (100)

No

31 (63.3)

18 (36.7)

 

25 (51)

24 (49)

 

49 (100)

HHV-6

Yes

14 (56)

11 (44)

0.374b

12 (48)

13 (52)

0.506b

25 (100)

No

19 (67.9)

9 (32.1)

 

16 (57.1)

12 (42.9)

 

28 (100)

HHV-7

Yes

14 (66.7)

7 (33.3)

0.592b

8 (381)

13 (61.9)

0.082b

21 (100)

No

19 (59.4)

13 (40.6)

 

20 (62.5)

12 (37.5)

 

32 (100)

HHV-8

Yes

5 (55.6)

4 (44.4)

0.715b

2 (22.2)

7 (77.8)

0.087b

9 (100)

No

28 (63.6)

16 (36.4)

 

26 (59.1)

18 (40.9)

 

44 (100)

  1. HSV herpes simplex virus, VZV varicella zoster virus, EBV Epstein–Barr virus, CMV cytomegalovirus, HHV human herpesvirus
  2. aFisher's exact test; bPearson's Chi-square test